Q1 2026 Hydreight Technologies Inc Earnings Call Transcript
Key Points
- Hydreight Technologies Inc (HYDTF) reported a record quarter with $25 million in revenue, surpassing the revenue of the first three quarters of 2025 combined.
- The company achieved profitability with an adjusted EBITDA of $3.3 million and net income of $2.6 million, marking the third consecutive quarter of margin expansion.
- Revenue grew 67% over the prior quarter without an increase in operating expenses, demonstrating strong operating leverage.
- The company closed the quarter with a strong financial position, holding $24.2 million in cash and $32 million in working capital.
- Hydreight Technologies Inc (HYDTF) reaffirmed its full-year guidance of a minimum of $150 million in revenue, indicating confidence in continued growth.
- The gross margin declined to approximately 20% from 33% a year ago due to a revenue mix shift towards lower-margin pharmacy sales.
- Operating expenses, while flat, still represent a significant portion of revenue, although they have decreased as a percentage of revenue.
- The company used $4.9 million to fund operating activities during the quarter, driven by an increase in working capital needs.
- The regulatory environment around digital health and telemedicine is tightening, which could pose challenges despite being seen as a tailwind by the company.
- The company's growth is heavily reliant on the successful execution of its existing partner relationships and current programs, with no assumed contribution from potential acquisitions or new markets.
Good morning, everyone, and welcome to Hydreight Technologies first quarter 2026 earnings conference call. (Operator Instructions) This call will be recorded as well. A replay will be made available on the company's Investor Relations website following this call, and we will send an email out shortly after to our shareholder list just in case you do have to leave for any reason. We're just going to give it a few moments before we begin as we see some people in the wait room, and we'll let them join here.
Also before we begin, please note that today's remarks contain forward-looking statements within the meaning of applicable Canadian securities laws. Actual results may differ materially from those expressed or implied today. For a discussion of the assumptions and risk factors involved, please refer to the company's MD&A and other continuous disclosure documents filed on SEDAR+ on the company's profile.
Today's discussions also reference certain non-GAAP financial measures, including adjusted revenue, adjusted gross margin and adjusted EBITDA. Reconciliations to the most comparable
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
